<ENAMEX TYPE="ORGANIZATION">Delmed Inc</ENAMEX> s top two officers resigned and were succeeded by executives of <ENAMEX TYPE="LOCATION">Fresenius USA Inc</ENAMEX> and its parent Fresenius AG a major Delmed holder that has been negotiating to acquire a controlling stake In addition Delmed which makes and sells a dialysis solution used in treating kidney diseases said negotiations about pricing had collapsed between it and a major distributor <ENAMEX TYPE="ORGANIZATION">National Medical Care Inc Delmed</ENAMEX> said Robert S Ehrlich resigned as chairman president and chief executive Mr Ehrlich will continue as a director and a consultant Leslie I Shapiro chief operating officer and chief financial officer also resigned the company said Mr Ehrlich was succeeded as chairman by Gerd Krick a director of Fresenius a West German pharmaceutical concern Ben Lipps president of <ENAMEX TYPE="LOCATION">Fresenius USA</ENAMEX> was named president chief executive and chief operating officer None of the officials was available for comment In trading on the <ENAMEX TYPE="ORGANIZATION">American Stock Exchange Delmed</ENAMEX> closed at 50 cents down 6 25 cents Fresenius owns about 42 of Delmed s fully diluted common stock The two companies have been discussing a transaction under which Fresenius would buy Delmed stock for cash to bring its beneficial ownership to between 70 and 80 of Delmed s fully diluted common stock The transaction also would combine <ENAMEX TYPE="LOCATION">Fresenius USA</ENAMEX> and Delmed Under the proposal Delmed would issue about 123 5 million additional Delmed common shares to Fresenius at an average price of about 65 cents a share though under no circumstances more than 75 cents a share Yesterday Delmed said it continues to explore the possibility of a combination with <ENAMEX TYPE="LOCATION">Fresenius USA</ENAMEX> It added that it is apparent that any terms of a combination would be substantially less favorable than those previously announced While the discussions between Delmed and <ENAMEX TYPE="ORGANIZATION">National Medical Care</ENAMEX> have been discontinued Delmed will continue to supply dialysis products through <ENAMEX TYPE="ORGANIZATION">National Medical</ENAMEX> after their exclusive agreement ends in March 1990 Delmed said In addition Delmed is exploring distribution arrangements with <ENAMEX TYPE="LOCATION">Fresenius USA Delmed</ENAMEX> said